The VERISMART Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 133 participants.

Also called NCT02490033

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 133 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02490033
Main results
  • Multicentre randomised trial comparing contact force with electrical coupling index in atrial flutter ablation (VERISMART trial) PloS one, 2019 DOI, PubMed 30943196, PMC6447159 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02490033. Randomized; no masking; primary purpose other. Start 2015-04-01 (registry gives no type); primary completion 2017-01-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The VERISMART Trial
Acronym
VERISMART
Intervention (Device)
Ablation Catheter
Lead sponsor
The Leeds Teaching Hospitals NHS Trust (class: other)
Collaborator
Biosense Webster, Inc. (class: industry)

Record details

Record id
cardio:ct-nct02490033
Content hash
072184073942c5046bc4097f6de04ad2af04d1a9311a5feb30d2c1f13e1ab6c3